CVS Health (CVS) Tops Q3 EPS by 33c, Raises FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- Tesla acquires AI hardware company for up to $2 billion in stock
CVS Health Reports Third Quarter Results With Diversified Assets Delivering Strong Enterprise Performance
November 6, 2020 6:30 AM ESTWOONSOCKET, R.I., Nov. 6, 2020 /PRNewswire/ --
Continued Responsiveness to COVID-19:
Ongoing support for employees, consumers and communities across the country Doubled the number of test sites to more than 4,000 CVS Pharmacy locations nationwide Selected to administer vaccines to long-term care facilities Consumer-driven health care model increases access to products and servicesThird Quarter Highlights:
Total revenues increased to $67.1 billion, up 3.5% compared to prior year GAAP diluted earnings per share of $0.93 and GAAP operating income of $3.2 billion Adjusted EPS... More